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A	  recent	  influx	  of	  pa0ents	  undergoing	  the	  transcatheter	  aor0c	  
valve	  replacement	  (TAVR)	  procedure	  sparked	  interest	  in	  the	  
pathophysiologic	  process	  of	  Aor0c	  Stenosis	  (AS),	  especially	  in	  
the	  geriatric	  popula0on.	  	  AS	  is	  mostly	  asymptoma0c	  un0l	  later	  
stages	  of	  the	  disease,	  which	  delays	  treatment	  and	  interven0on	  
leading	  to	  poor	  outcomes	  and	  prognosis,	  especially	  for	  those	  
who	  are	  not	  surgical	  candidates.	  	  The	  TAVR	  procedure	  has	  
allowed	  pa0ents	  who	  are	  otherwise	  not	  candidates	  for	  open	  
heart	  surgery	  undergo	  valve	  replacement	  in	  a	  low	  risk	  fashion,	  
prolonging	  life	  and	  improving	  quality	  of	  life.	  	  AS	  causes	  an	  
increase	  in	  aDerload,	  decreasing	  ouElow	  of	  blood	  from	  the	  leD	  
ventricle.	  	  This	  process	  can	  lead	  to	  an	  array	  of	  complica0ons	  
including	  leD	  sided	  heart	  failure.	  The	  underlying	  
pathophysiologic	  process	  of	  AS	  will	  be	  outlined	  in	  this	  
presenta0on.	  	  
Introduc5on	  
Facts	  about	  AS	  
Subjec5ve	  Findings	  
Objec5ve	  Findings	  
•  1.5	  million	  suffer	  from	  AS	  in	  the	  U.S,	  with	  calcific	  AS	  being	  
the	  most	  common	  	  
•  Severe	  AS	  has	  a	  5	  year	  survival	  rate	  of	  3%	  without	  surgical	  
interven0on,	  which	  is	  lower	  than	  many	  metasta0c	  cancers	  	  
•  AS	  is	  usually	  seen	  in	  those	  greater	  than	  75	  years	  of	  age	  	  
•  Only	  about	  half	  of	  	  those	  who	  suffer	  from	  severe	  AS	  are	  
symptoma0c.	  
(Chen,	  2014)	  
•  Shortness	  of	  breath	  (SOB)	  upon	  exer0on	  or	  at	  rest	  with	  
severe	  AS	  	  
  Secondary	  to	  leD	  ventricular	  heart	  failure	  
and	  subsequent	  pulmonary	  conges0on	  
•  Angina	  
  May	  be	  related	  to	  increased	  workload	  on	  
the	  leD	  ventricle	  and	  a	  subsequent	  
increase	  in	  oxygen	  consump0on	  
  Typically	  exacerbated	  by	  ac0vity	  and	  
relieved	  with	  rest	  
•  Syncope	  
  Likely	  related	  to	  a	  decrease	  in	  cardiac	  
output	  and	  a	  subsequent	  decrease	  in	  
cerebral	  perfusion	  
  May	  be	  precipitated	  by	  high	  leD	  
ventricular	  pressures	  causing	  acute	  
baroreceptor-­‐ac0vated	  vasodila0on	  
leading	  to	  decreased	  cardiac	  output	  
•  Palpita0ons	  
  Likely	  a	  sensa0on	  resul0ng	  from	  atrial	  
fibrilla0on	  or	  sinus	  tachycardia	  
•  Increased	  fa0gability	  and	  decline	  in	  ac0vity	  	  	  	  	  	  	  	  	  
(Cary	  &	  Pearce,	  2013).	  
•  Systolic	  ejec0on	  murmur	  upon	  ausculta0on	  of	  heart	  
tones,	  best	  heard	  between	  2nd	  intercostal	  space	  on	  right	  
sternal	  border,	  occurring	  aDer	  S1	  and	  ending	  before	  S2.	  	  
•  Pulmonary	  crackles	  upon	  ausculta0on	  secondary	  to	  
conges0ve	  heart	  failure	  and	  pulmonary	  conges0on	  
•  Jugular	  vein	  disten0on	  may	  be	  present	  in	  severe	  AS	  
•  Tachycardia,	  or	  other	  cardiac	  arrhythmias	  such	  as	  atrial	  
fibrilla0on	  (Afib)	  or	  Atrioventricular	  blocks	  may	  be	  
present	  
•  Hypotension	  
•  Decreased	  oxygen	  satura0on	  
•  Other	  Hemodynamic	  changes	  are	  outlined	  in	  the	  table	  
below.	  
(Cary	  &	  Pearce,	  2013).	  
Underlying	  Pathophysiologic	  Process	  
•  Mul0ple	  pathological	  processes	  are	  thought	  to	  play	  a	  role	  in	  the	  development	  of	  	  
aor0c	  stenosis	  	  
•  Biomechanical	  forces	  	  
  Create	  an	  increase	  in	  stretch	  and	  shear	  on	  the	  valve	  cusps,	  producing	  
inflamma0on	  and	  extracellular	  remodeling	  	  
•  Lipid	  accumula0on	  	  
  Oxidized	  LDL	  engulfed	  by	  macrophages	  create	  foam	  cells.	  	  These,	  along	  
with	  T	  lymphocytes,	  ac0vate	  proinflammatory	  cytokines,	  which	  
promote	  apoptois	  and	  0ssue	  remodeling	  with	  subsequent	  fibrosis	  and	  
calcifica0on.	  	  
•  Calcifica0on	  
  Valvular	  inters00al	  cells	  (VICs)	  differen0ate	  and	  proliferate	  into	  
myofibroblasts,	  induced	  by	  a	  combina0on	  of	  mechanical	  forces,	  
inflammatory	  markers	  and	  growth	  factors,	  which	  replace	  normal	  0ssue	  
with	  dense	  collagen	  and	  bone,	  leaving	  the	  valve	  s0ff	  and	  non-­‐
compliant.	  
(Gould,	  Simmons	  &	  Anseth,	  2013).	  
Significance	  of	  Pathophysiology	  
•  Pathophysiology	  of	  AS	  can	  lead	  to	  decompensa0on	  of	  leD	  ventricle	  because	  of	  
increased	  workload	  and	  oxygen	  demand,	  leading	  to	  heart	  failure	  and	  pulmonary	  
conges0on.	  (Cary	  &	  Pearce,	  2013).	  
•  Severe	  AS	  can	  lead	  to	  life	  threatening	  symptoms	  such	  angina,	  syncope,	  and	  cardiac	  
arrest	  (Towler,	  2013).	  
•  Understanding	  of	  pathophysiological	  process	  of	  AS	  is	  key	  to	  medical	  management	  
  Possible	  use	  of	  an0-­‐inflammatory	  drugs	  to	  decrease	  calcifica0on	  and	  	  	  	  	  
remodeling	  (Gould,	  Simmons	  &	  Anseth,	  2013).	  
  An0-­‐lipid	  agents	  to	  decrease	  cholesterol	  and	  subsequent	  reduc0on	  in	  
oxidized	  LDL	  (Gould,	  Simmons	  &	  Anseth,	  2013).	  
  Vasodilators,	  diure0cs,	  and	  possibly	  beta	  blockers	  help	  to	  reduce	  leD	  
ventricular	  workload	  and	  decrease	  shear	  and	  stress	  on	  valvular	  0ssue	  
(Cary	  &	  Pearce,	  2013).	  
o  Special	  considera0on	  with	  beta	  blockers,	  as	  to	  not	  
poten0ate	  systolic	  heart	  failure.	  	  
•  Surgical	  replacement	  of	  aor0c	  valve	  gold	  standard	  treatment	  (open	  chest	  or	  TAVR).	  Poor	  
prognosis	  for	  medically	  managed	  pa0ents	  (Towler,	  2013).	  
Implica5ons	  for	  Nursing	  Care	  
•  The	  nurse	  caring	  for	  the	  pa0ent	  must	  be	  highly	  aware	  of	  the	  pathophysiologic	  process	  of	  
AS,	  as	  well	  as	  treatment	  and	  possible	  complica0ons	  (Cary	  &	  Pearce,	  2013).	  
•  Deep	  understanding	  of	  strict	  range	  of	  preload	  and	  aDerload	  to	  maintain	  adequate	  cardiac	  
output	  (Gould,	  Simmons	  &	  Anseth,	  2013).	  
•  Maintenance	  of	  ac0vity	  to	  balance	  oxygen	  supply	  and	  demand	  (Cary	  &	  Pearce,	  2013).	  
•  Thorough	  focused	  assessment	  of	  pa0ent	  including,	  but	  not	  limited	  to,	  ausculta0on	  of	  
heart	  tones	  and	  breath	  sounds,	  presence	  of	  jugular	  vein	  disten0on,	  cyano0c	  or	  dusky	  
appearance,	  hemodynamics,	  heart	  rate	  and	  rhythm,	  and	  presence	  of	  edema	  are	  crucial	  in	  
the	  iden0fica0on	  and	  differen0a0on	  of	  possible	  complica0ons	  (Cary	  &	  Pearce,	  2013).	  
•  Clinical	  awareness	  of	  decompensa0on	  of	  pa0ent	  including	  decreased	  oxygen	  satura0ons,	  
shortness	  of	  breath,	  angina,	  hypotension,	  cardiac	  arrhythmias,	  and	  chest	  pain	  is	  crucial	  
(Gould,	  Simmons	  &	  Anseth,	  2013).	  
•  Angina	  unrelieved	  with	  oxygen,	  rest,	  and	  nitrate	  therapy	  or	  associated	  with	  hypotension	  
may	  prompt	  intra-­‐aor0c	  balloon	  pump	  therapy	  to	  augment	  coronary	  perfusion	  and	  
decrease	  myocardial	  workload	  (Cary	  &	  Pearce,	  2013).	  
•  Educa0on	  must	  be	  provided	  to	  pa0ents	  
	  	  	  	  	  	  	  	  	  diagnosed	  with	  aor0c	  stenosis	  regarding	  	  
	  	  	  	  	  	  	  	  	  recogni0on	  of	  worsening	  	  signs	  and	  	  
	  	  	  	  	  	  	  	  	  symptoms	  and	  	  prompt	  repor0ng	  of	  these	  	  
	  	  	  	  	  	  	  	  	  changes	  to	  their	  health	  care	  provider	  
	  	  	  	  	  	  	  	  	  (Cary	  &	  Pearce,	  2013).	  
Conclusion	  
Grading	  AS	  
•  Graded	  as	  mild,	  moderate	  or	  severe	  (Kurtz	  &	  Oco,	  2010).	  
•  Three	  parameters	  are	  used	  in	  diagnosis,	  which	  are	  
assessed	  through	  Doppler	  Echocardiogram	  (Kurtz	  &	  Ocp,	  
2010).	  	  
  Aor0c	  jet	  velocity	  
  Mean	  aor0c	  valve	  pressure	  gradient	  	  
  Aor0c	  valve	  area	  
•  According	  to	  Cary	  and	  Pearce	  (2013),	  “Aor0c	  jet	  velocity	  is	  
a	  direct	  measurement	  of	  the	  severity	  of	  stenosis	  and	  is	  
the	  strongest	  predictor	  of	  clinical	  outcome”	  (p.	  63-­‐34).	  
•  	  AS	  is	  considered	  hemodynamically	  significant	  when	  the	  
aor0c	  valve	  area	  is	  less	  than	  1.0	  cm².	  
•  Oco	  (2010)	  defines	  severe	  AS	  as,	  “the	  degree	  of	  valve	  
obstruc0on	  at	  which	  symptoms	  might	  be	  caused	  by	  valve	  
obstruc0on”	  (p.	  280).	  
•  Grading	  specifica0ons	  based	  on	  findings	  from	  
echocardiogram	  are	  outlined	  below	  (Cary	  &	  Pearce,	  
2013).	  
AS	  is	  a	  disease	  that	  affects	  roughly	  one	  and	  a	  half	  million	  people	  in	  the	  United	  States	  alone	  
(Chen,	  2014).	  	  Calcific	  Aor0c	  Stenosis	  is	  the	  most	  common	  type,	  and	  mul0ple	  pathophysiologic	  
processes	  contribute	  to	  the	  development	  of	  this	  disease.	  	  Mechanical	  stress	  on	  the	  valve	  over	  
0me	  can	  cause	  inflamma0on	  and	  remodeling	  of	  the	  0ssue,	  rendering	  the	  valve	  dysfunc0onal.	  	  
Oxidized	  lipids	  that	  accumulate	  in	  the	  valvular	  0ssue	  ac0vate	  the	  immune	  system	  and	  other	  
biochemical	  substances	  that	  promote	  apoptosis	  of	  valvular	  cells,	  fibrosis,	  and	  calcifica0on.	  	  
Also,	  both	  of	  these	  processes	  combined	  can	  cause	  differen0a0on	  of	  VIC’s	  into	  myofibroblasts,	  
replacing	  normal	  0ssue	  with	  dense	  collagen	  and	  bone	  leaving	  the	  valve	  s0ff	  and	  non-­‐compliant	  
(Gould,	  Simmons	  &	  Anseth,	  2013).	  	  Understanding	  the	  underlying	  pathophysiology	  of	  AS	  can	  
help	  health	  care	  providers	  becer	  care	  for	  these	  pa0ents,	  as	  well	  as	  develop	  future	  treatments	  
that	  may	  decrease	  mortality	  and	  improve	  outcomes.	  The	  nurse	  must	  have	  a	  firm	  grasp	  on	  the	  
process	  of	  this	  disease	  in	  order	  to	  effec0vely	  care	  for	  the	  pa0ent	  in	  the	  acute	  care	  sejng.	  	  
Thorough	  assessment,	  knowing	  signs	  and	  symptoms	  of	  AS,	  as	  well	  as	  being	  able	  to	  iden0fy	  the	  
decompensa0ng	  pa0ent	  is	  key	  to	  successful	  care	  of	  a	  pa0ent	  with	  AS.	  	  Surgical	  interven0on	  is	  
the	  gold	  standard	  of	  treatment	  for	  AS,	  as	  medically	  managed	  pa0ents	  have	  extremely	  poor	  
outcomes.	  The	  TAVR	  procedure	  has	  helped	  those	  who	  are	  not	  typically	  surgical	  candidates	  
undergo	  valve	  replacement,	  improving	  outcomes	  and	  quality	  of	  life	  in	  many	  pa0ents	  (Towler,	  
2013).	  	  Further	  research	  on	  the	  pathophysiological	  process	  of	  AS	  can	  hopefully	  guide	  the	  
development	  of	  pharmacological	  advances	  that	  may	  help	  improve	  outcomes	  and	  decrease	  
mortality	  rates	  in	  medically	  managed	  pa0ents	  with	  AS.	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